Follow-Up of High-Grade Glial Tumor; Differentiation of Posttreatment Enhancement and Tumoral Enhancement by DCE-MR Perfusion

Table 1

The distribution of enhancement type and tumor grade of patients are given in cross-table.

Tumor grade		3	4	Total
Posttreatmeant enhancement	n	2	5	7
	%	28.6%	71.4%	100.0%
Tumoral enhancement	n	9	18	27
	%	33.3%	66.7%	100.0%
Total	n	11	23	34
	%	32.4%	67.6%	100.0%